Filed: 5/15/2025ACC: 0001315863-25-000400
📋 What this filing means
CRESTLINE MANAGEMENT, L.P. filed this quarterly 13F‑HR report disclosing 3 equity positions with a total reported market value of $63.24M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
3
Positions
$63.24M
Total AUM (reported)
7.94M
Total Shares
Allocation by class
COM$63.24M100.0%
Portfolio Concentration
Top 3$63.24M100.0%
Top 3 weight
100.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 7.94M
Sole
Full voting authority
7.94M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole3
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings3
Rows:
DENALI THERAPEUTICS INC
SOLEShares4.16M
TypeSH
Market value$56.57M
89.45%
Sole
4.16M
Shared
0.00
None
0.00
SANA BIOTECHNOLOGY INC
SOLEShares2.79M
TypeSH
Market value$4.69M
7.41%
Sole
2.79M
Shared
0.00
None
0.00
8X8 INC NEW
SOLEShares990.58K
TypeSH
Market value$1.98M
3.13%
Sole
990.58K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
DENALI THERAPEUTICS INCSOLE | COM | 4.16M | SH | $56.57M 89.45% | 4.16M | 0.00 | 0.00 |
SANA BIOTECHNOLOGY INCSOLE | COM | 2.79M | SH | $4.69M 7.41% | 2.79M | 0.00 | 0.00 |
8X8 INC NEWSOLE | COM | 990.58K | SH | $1.98M 3.13% | 990.58K | 0.00 | 0.00 |